Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1019 (LINC01019) encodes a long non-coding RNA that is autonomously transcribed and does not overlap any protein-coding gene loci[1][3][7]. LincRNAs such as LINC01019 play diverse roles in chromatin remodeling, transcriptional regulation, and RNA stabilization, often acting in the nucleus to modulate gene expression through epigenetic mechanisms or as enhancer-like elements[3][7][11]. While the broader family of lincRNAs is increasingly recognized for their involvement in critical biological processes and disease, especially cancer, specific biological functions and disease links for LINC01019 remain to be fully elucidated[1][11]. There are currently no known drugs targeting this lincRNA, and it is not used as a biomarker or associated with special safety concerns for therapy[1][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1019 (LINC01019).